This is a non-core endpoint: only basic statistics are computed.
Abnormalities of gait and mobility
R18_ABNORMALITI_GAIT_MOBIL
gait apraxia: Impaired ambulation not attributed to sensory impairment or motor weakness. frontal lobe disorders; basal ganglia diseases (e.g., parkinsonian disorders); dementia, multi-infarct; alzheimer disease; and other conditions may be associated with gait apraxia.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
3192
Check minimum number of events None
3192
Include endpoints None
3192
Remove individuals based on genotype QC
3080
R18_ABNORMALITI_GAIT_MOBIL
Control definitions
Control exclude
R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
Extra metadata
Level in the ICD hierarchy
3
Special
GAITCHANGE
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R25-R29
Name in latin
Abnormitates incessus et mobilitatis
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Abnormalities of gait and mobility
based on the number of shared cases.
Broader endpoints:
- Symptoms and signs involving the nervous and musculoskeletal systems
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3080 | 1423 | 1657 |
| Unadjusted prevalence (%) | 0.82 | 0.68 | 1.00 |
| Mean age at first event (years) | 63.84 | 60.10 | 67.06 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: R18_ABNORMALITI_GAIT_MOBIL – Abnormalities of gait and mobility
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Abnormalities of gait and mobility
↥Endpoint not on priority list, no data to show.